# Lexeo Therapeutics

**Source:** https://www.startuphub.ai/startups/lexeo-therapeutics
**Profile type:** Startup

> Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

## About

Lexeo Therapeutics is a New York City-based, clinical-stage genetic medicine company focused on developing AAV-mediated treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease. The company leverages pioneering science and a stepwise development approach to advance its pipeline of therapeutic candidates, aiming to address significant unmet medical needs.

## Key facts

- **Slug:** lexeo-therapeutics
- **Website:** https://www.lexeotx.com/
- **Location:** New York City, United States
- **Founded:** 2020-01-01
- **Employees:** 91
- **Operating status:** Active
- **Total funding:** $495M
- **Sectors / tags:** Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials, Gene Therapy, Cardiovascular Diseases, Alzheimer's Disease, Neurology
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/lexeo-therapeutics

## Frequently asked

### What does Lexeo Therapeutics do?

Lexeo Therapeutics is a New York City-based, clinical-stage genetic medicine company focused on developing AAV-mediated treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease. The company leverages pioneering science and a stepwise development approach to advance its pipeline of therapeutic candidates, aiming to address significant unmet medical needs.

### What is Lexeo Therapeutics's revenue?

StartupHub estimates Lexeo Therapeutics's annual revenue at $77.8M (range $28.7M to $189.7M, 27% confidence), based on comparable companies in the sector.

### What is Lexeo Therapeutics's valuation?

StartupHub estimates Lexeo Therapeutics's effective valuation at $2.1B (range $1.2B to $3.0B, 19% confidence), based on comparable companies in the sector.

### How much funding has Lexeo Therapeutics raised?

Lexeo Therapeutics has raised a total of $495M in funding. The most recent round on record is Public Offering.

### Where is Lexeo Therapeutics headquartered?

Lexeo Therapeutics is headquartered in New York City, United States.

### When was Lexeo Therapeutics founded?

Lexeo Therapeutics was founded in 2020.

### What industry does Lexeo Therapeutics operate in?

Lexeo Therapeutics operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.

### How many employees does Lexeo Therapeutics have?

Lexeo Therapeutics has approximately 91 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Lexeo Therapeutics",
          "item": "https://www.startuphub.ai/startups/lexeo-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/lexeo-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/lexeo-therapeutics",
      "name": "Lexeo Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Lexeo Therapeutics. Lexeo Therapeutics is a startup founded in 2020, operating in Biotech and MedTech. Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. Headquartered in New York City, United States. The company has approximately 91 employees.",
      "dateModified": "2026-05-01T10:39:55.16296+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/lexeo-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/lexeo-therapeutics#organization",
      "name": "Lexeo Therapeutics",
      "url": "https://www.lexeotx.com/",
      "description": "This is the official profile of Lexeo Therapeutics. Lexeo Therapeutics is a startup founded in 2020, operating in Biotech and MedTech. Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. Headquartered in New York City, United States. The company has approximately 91 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/lexeo-therapeutics",
        "https://www.startuphub.ai/startups/lexeo-therapeutics"
      ],
      "foundingDate": "2020-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 91
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "New York City",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotech",
        "MedTech",
        "HealthTech",
        "Genomics",
        "Drug Discovery",
        "Clinical Trials",
        "Gene Therapy",
        "Cardiovascular Diseases",
        "Alzheimer's Disease",
        "Neurology"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/lexeo-therapeutics#profile-assessment",
      "name": "Lexeo Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/lexeo-therapeutics",
      "category": "Biotech",
      "description": "This is the official profile of Lexeo Therapeutics. Lexeo Therapeutics is a startup founded in 2020, operating in Biotech and MedTech. Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. Headquartered in New York City, United States. The company has approximately 91 employees. Agent Readiness score: 39/100. Full audit: https://www.startuphub.ai/startups/lexeo-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Lexeo Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-01",
        "name": "Lexeo Therapeutics - Profile Score 63/100",
        "reviewBody": "This is the official profile of Lexeo Therapeutics. Lexeo Therapeutics is a startup founded in 2020, operating in Biotech and MedTech. Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. Headquartered in New York City, United States. The company has approximately 91 employees. Agent Readiness score: 39/100. Full audit: https://www.startuphub.ai/startups/lexeo-therapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 63,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```